✦ LIBER ✦

Citalopram treatment of compulsive shopping: An open-label pilot study

✍ Scribed by L.M. Koran; K.D. Bullock; H.J. Hartston; M.A. Elliott; V. D'Andrea

Book ID: 119575598
Publisher: Elsevier Science
Year: 2001
Tongue: English
Weight: 152 KB
Volume: 11
Category: Article
ISSN: 0924-977X
DOI: 10.1016/s0924-977x(01)80498-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Citalopram in the treatment of obsessive

Citalopram in the treatment of obsessive-compulsive disorder: an open pilot study

✍ H. Koponen; U. Lepola; E. Leinonen; R. Jokinen; J. Penttinen; J. Turtonen 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 414 KB

Open-label pilot study of tramadol hydro

Open-label pilot study of tramadol hydrochloride in treatment-refractory obsessive-compulsive disorder

✍ Nathan A. Shapira; Paul E. Keck Jr.; Toby D. Goldsmith; Brian J. McConville; Mic 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 54 KB 👁 2 views

Citalopram Treatment of Minor Depression

Citalopram Treatment of Minor Depression in Elderly Men: An Open Pilot Study

✍ Kasckow, John W.; Welge, Jeff; Carroll, Brendan T.; Thalassinos, Arthur; Mohamed 📂 Article 📅 2002 🏛 American Psychiatric Publishing Inc 🌐 English ⚖ 75 KB

Rituximab in the treatment of dermatomyo

Rituximab in the treatment of dermatomyositis: An open-label pilot study

✍ Todd D. Levine 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 93 KB 👁 2 views

Citalopram Treatment for Impulsive Aggre

Citalopram Treatment for Impulsive Aggression in Children and Adolescents: An Open Pilot Study

✍ ARMENTEROS, JORGE L.; LEWIS, JOHN E. 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 135 KB

Duloxetine in the treatment of irritable

Duloxetine in the treatment of irritable bowel syndrome: an open-label pilot study

✍ Brian P. Brennan; Kate V. Fogarty; Jacqueline L. Roberts; Karina A. Reynolds; Ha 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 94 KB 👁 2 views

## Abstract ## Objective To assess the efficacy of duloxetine for irritable bowel syndrome (IBS). ## Methods We conducted an open‐label 12‐week trial of duloxetine 60 mg daily in 15 patients with IBS without concurrent major depressive disorder. The primary outcome measure was average abdominal